Company News
Mosaic Therapeutics appoints Dr Barry Davies as its CSO
Mosaic Therapeutics appoints Dr Barry Davies as its CSO
Barry will bring more than 25 years of experience in drug development and lead optimisation to the table
Lonza nominates David Meline as independent board member
Lonza nominates David Meline as independent board member
David Meline brings extensive governance, financial and industry experience to Lonza’s Board of Directors
Nanosyrinx appoints Edwin Moses as its Chairperson
Nanosyrinx appoints Edwin Moses as its Chairperson
With more than 30 years of executive-level experience, Edwin will aim to maximise the value of the company's nanosyringe platform
Enzene appoints Norm Stoffregen as Site Head of its US biomanufacturing facility
Enzene appoints Norm Stoffregen as Site Head of its US biomanufacturing facility
The CDMO has appointed Norm to run the USD $50m manufacturing facility in New Jersey
Amphista Therapeutics appoints new CEO, Antony Mattessich
Amphista Therapeutics appoints new CEO, Antony Mattessich
Antony will be responsible for assisting the growth and development of the company and its therapeutic assets
Johnson & Johnson's Kristen Mulholland appointed as Chief Human Resources Officer
Johnson & Johnson's Kristen Mulholland appointed as Chief Human Resources Officer
Kristen will replace Peter Fasolo, who will retire after 16 years of service for the company
Jochen Schmidt appointed new Managing Director of Romaco Pharmatechnik GmbH
Jochen Schmidt appointed new Managing Director of Romaco Pharmatechnik GmbH
Romaco Holding GmbH has just appointed Jochen Schmidt as new Managing Director of Romaco Pharmatechnik GmbH. He will be responsible with immediate effect for the Romaco...
Bio X Cell appoints Christopher Conway as CEO
Bio X Cell appoints Christopher Conway as CEO
Christopher will work with the executive board members to guide the company's global expansion strategy
Emirates Biotech bolsters executive board with four new appointments
Emirates Biotech bolsters executive board with four new appointments
The company has brought in a new CEO, CCO, CTO and a Head of Finance to boost its footprint in the Middle East, Africa and India
Corex Logistics appoints Steve Healy as its new CEO
Corex Logistics appoints Steve Healy as its new CEO
Steve will guide the company's global expansion initiative
Lonza appoints Juan Andres and Eric Drapé to its Board as independent members
Lonza appoints Juan Andres and Eric Drapé to its Board as independent members
The two bring a wealth of pharmaceutical knowledge, and have worked in a number of leadership positions at pharma giants such as Novo Nordisk, Moderna and Eli Lilly
Steve Becker joins Broken String Biosciences as Chief Commercial Officer
Steve Becker joins Broken String Biosciences as Chief Commercial Officer
Steve's will help to push the company's INDUCE-seq commercialisation strategy forward
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Chris' appointment will assist the company in making its commercial growth plans a reality
Optibrium appoints James Halle as Chief Commercial Officer
Optibrium appoints James Halle as Chief Commercial Officer
James will assist the company in commercialising StarDrop, Cerella and Semeta, the company's proprietary drug development platforms
Cherwell appoints Andy Charteris as new Director of Operations
Cherwell appoints Andy Charteris as new Director of Operations
Andy will assist Cherwell in its plans to acceleration its growth in the cleanroom space
Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science
Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science
The award was appointed to Dr Gloria Gonzalez-Aseguinolaza for her work in advancing cell and gene therapies
Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer
Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer
Dr Appleby has extensive experience in the development and commercialisation of both conventional and advanced therapeutics
Cellular Origins appoints Geoffrey Hodge as Non-Executive Director
Cellular Origins appoints Geoffrey Hodge as Non-Executive Director
Geoff will contribute to the company's commercial growth efforts while also shaping the future direction of Cellular Origins
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors
Luke brings more than 35 years of experience to the role, and has been non-executive director of a range of large biopharmaceutical companies
etherna appoints Antonin de Fougerolles as new Chairperson
etherna appoints Antonin de Fougerolles as new Chairperson
Tony has extensive experience in the development of novel therapeutic modalities, such as RNAis and modified mRNAs for vaccinations
Selkirk Pharma appoints Colleen Dixon as CEO
Selkirk Pharma appoints Colleen Dixon as CEO
Colleen has more than 30 years of experience in the pharmaceutical industry, and will succeed Patrick Haffey
Newcells Biotech appoints Emile Shaffu as Director of Sales
Newcells Biotech appoints Emile Shaffu as Director of Sales
Emile will work with Newcells to expand its global presence, as well as boost its customer service capabilities
H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor
H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor
Prof. Duh will continue to assist H.E.L Group in developing its battery calorimeters and lithium ion battery testing protocols
Lonza appoints Wolfgang Wienand as the group’s CEO
Lonza appoints Wolfgang Wienand as the group’s CEO
Wolfgang will lead Lonza as the CDMO continues to push its growth and customer satisfaction